Salivary Mucoepidermoid Carcinoma: Demonstration of Transcriptionally Active Human Papillomavirus 16/18

Head and Neck Pathology

Volumn 7, Issue 2, 2013, Pages 135-148

  Isayeva, Tatyana ^a   Said Al Naief, Nasser ^b   Ren, Zhiyong ^a   Li, Rong ^a   Gnepp, Douglas ^c   Brandwein Gensler, Margaret ^a  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF THE PACIFIC   (United States)

^c RHODE ISLAND HOSPITAL   (United States)

Author keywords

E6; HPV16 18; Human Papillomavirus; Mucoepidermoid carcinoma

Indexed keywords

DNA BINDING PROTEIN; E6 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18; ONCOPROTEIN; VIRUS DNA;

ADENOSQUAMOUS CARCINOMA; ARTICLE; FEMALE; GENETICS; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; IN SITU HYBRIDIZATION; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; PATHOLOGY; SALIVARY GLAND TUMOR; VIROLOGY; VIRUS CELL TRANSFORMATION;

CARCINOMA, MUCOEPIDERMOID; CELL TRANSFORMATION, VIRAL; DNA, VIRAL; DNA-BINDING PROTEINS; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; ONCOGENE PROTEINS, VIRAL; SALIVARY GLAND NEOPLASMS;

EID: 84877076041     PISSN: 1936055X     EISSN: 19360568     Source Type: Journal    
DOI: 10.1007/s12105-012-0411-2     Document Type: Article

References (41)

1. Bleyer A. Cancer of the oral cavity and pharynx in young females: increasing incidence, role of human papilloma virus, and lack of survival improvement. Semin Oncol. 2009; 36: 451-9.
2. Vageli D, Sourvinos G, Ioannou M, Koukoulis GK, Spandidos DA. High-risk human papillomavirus (HPV) in parotid lesions. Int J Biol Markers. 2007; 22: 239-44.
3. Duray A, Descamps G, Arafa M, et al. High incidence of high-risk HPV in benign and malignant lesions of the larynx. Int J Oncol. 2011; 39: 51-9.
4. Bai S, Clubwala R, Adler E, Sarta C, Schiff B, Smith RV, Gnepp D, Brandwein-Gensler M. Salivary mucoepidermoid carcinoma: a multi-institutional review of 76 patients. Head Neck Pathol 2012; doi: 10. 1007/s12105-012-0405.
5. Brandwein MS, Ivanov K, Wallace DI, Hille JJ, Wang B, Fahmy A, Bodian C, Urken ML, Gnepp DR, Huvos A, Lumerman H, Mills SE. Mucoepidermoid carcinoma: a clinicopathologic study of 80 patients with special reference to histological grading. Am J Surg Pathol. 2001; 25: 835-45.
6. de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ, Snijders PJ. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol. 1995, 76: 1057-1062.
7. Jacobs MV, de Roda Husman AM, van den Brule AJ, Snijders PJ, Meijer CJ, Walboomers JM. Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes. J Clin Microbiol. 1995; 33: 901-5.
8. Evans MF, Adamson CS, Simmons-Arnold L, Cooper K. Touchdown General Primer (GP5+/GP6+) PCR and optimized sample DNA concentration support the sensitive detection of human papillomavirus. BMC Clin Pathol. 2005;. doi: 10. 1186/1472-6890-5-10.
9. Pannone G, Rodolico V, Santoro A, Lo Muzio L, Franco R, Botti G, Aquino G, Pedicillo MC, Cagiano S, Campisi G, Rubini C, Papagerakis S, De Rosa G, Tornesello ML, Buonaguro FM, Staibano S, Bufo P. Evaluation of a combined triple method to detect causative HPV in oral and oropharyngeal squamous cell carcinomas: p16 Immunohistochemistry, Consensus PCR HPV-DNA, and In Situ Hybridization. Infect Agent Cancer. 2012 doi: 10. 1186/1750-9378-7-4.
10. Hopman AH, Kamps MA, Smedts F, Speel EJ, Herrington CS, Ramaekers FC. HPV in situ hybridization: impact of different protocols on the detection of integrated HPV. Int J Cancer. 2005; 115: 419-28.
11. Miyabe S, Okabe M, Nagatsuka H, Hasegawa Y, Inagaki A, Ijichi K, Nagai N, Eimoto T, Yokoi M, Shimozato K, Inagaki H. Prognostic significance of p27Kip1, Ki-67, and CRTC1-MAML2 fusion transcript in mucoepidermoid carcinoma: a molecular and clinicopathologic study of 101 cases. J Oral Maxillofac Surg. 2009; 67: 1432-41.
12. Auclair PL, Ellis GL, Gnepp DR, Wenig BM, Janney CG: Salivary gland neoplasms: General considerations. In: Surgical pathology of the salivary glands. Ellis GL, Auclair PL, Gnepp DR editors, 1991, WB Saunders, Philadelphia.
13. Seoud M, Tjalma WA, Ronsse V. Cervical adenocarcinoma: moving towards better prevention. Vaccine. 2011; 29: 9148-58.
14. Wilczynski SP, Bergen S, Walker J, Liao SY, Pearlman LF. Human papillomaviruses and cervical cancer: analysis of histopathologic features associated with different viral types. Hum Pathol. 1988; 19: 697-704.
15. Boland JM, McPhail ED, García JJ, Lewis JE, Schembri-Wismayer DJ. Detection of human papilloma virus and p16 expression in high-grade adenoid cystic carcinoma of the head and neck. Mod Pathol. 2012; 25: 529-36.
16. Brunner M, Koperek O, Wrba F, Erovic BM, Heiduschka G, Schoppper C, Thurnher D. HPV infection and p16 expression in carcinomas of the minor salivary glands. Eur Arch Otorhinolaryngol. 2012; 269: 2265-9.
17. Hafed L, Farag H, Shaker O, El-Rouby D. Is human papilloma virus associated with salivary gland neoplasms? An in situ-hybridization study. Arch Oral Biol. 2012; 57: 1194-9.
18. Schlecht NF, Brandwein-Gensler M, Nuovo GJ, Li M, Smith RV, Burk RD, Prystowsky MB. A comparison of clinically utilized human papillomavirus detection methods in head and neck cancer. Modern Pathol. 2011; 24: 1295-305.
19. Smith EM, Rubenstein LM, Haugen TH, Pawlita M, Turek LP. Complex etiology underlies risk and survival in head and neck cancer human papillomavirus, tobacco, and alcohol: a case for multifactor disease. J Oncol. 2012; 2012: 571862.
20. Westra WH, Taube JM, Poeta ML, Begum S, Sidransky D, Koch WM. Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck. Clin Cancer Res. 2008; 14: 366-9.
21. Guo XL, Sun SZ, Wang WX, Wei FC, Yu HB, Ma BL. Alterations of p16INK4a tumour suppressor gene in mucoepidermoid carcinoma of the salivary glands. Int J Oral Maxillofac Surg. 2007; 36: 350-3.
22. Kiyoshima T, Shima K, Kobayashi I, Matsuo K, Okamura K, Komatsu S, Rasul AM, Sakai H. Expression of p53 tumor suppressor gene in adenoid cystic and mucoepidermoid carcinomas of the salivary glands. Oral Oncol. 2001; 37: 315-22.
23. Wolfish EB, Nelson BL, Thompson LD. Sinonasal tract mucoepidermoid carcinoma: a clinicopathologic and immunophenotypic study of 19 cases combined with a comprehensive review of the literature. Head Neck Pathol. 2012; 6: 191-207.
24. Gomes CC, Diniz MG, Orsine LA, Duarte AP, Fonseca-Silva T, Conn BI, De Marco L, Pereira CM, Gomez RS. Assessment of TP53 mutations in benign and malignant salivary gland neoplasms. PLoS ONE. 2012; 7: e41261.
25. Al-Rawi NH, Omer H, Al Kawas S. Immunohistochemical analysis of P(53) and bcl-2 in benign and malignant salivary glands tumors. J Oral Pathol Med. 2010; 39: 48-55.
26. Jung AC, Briolat J, Millon R, de Reyniès A, Rickman D, Thomas E, Abecassis J, Clavel C, Wasylyk B. Biological and clinical relevance of transcriptionally active human papillomavirus (HPV) infection in oropharynx squamous cell carcinoma. Int J Cancer. 2010; 126: 1882-94.
27. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by HPV16 and 18 promotes the degradation of p53. Cell. 1990; 63: 1129-36.
28. Scheffner M, Whitaker NJ. HPV-induced carcinogenesis and the ubiquitin-proteasome system. Sem Canc Biol. 2003; 13: 59-67.
29. Tonon G, Modi S, Wu L, Kubo A, Coxon AB, Komiya T, O'Neil K, Stover K, El-Naggar A, Griffin JD, Kirsch IR, Kaye FJ. t(11; 19)(q21; p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway. Nat Genet. 2003; 33: 208-13.
30. Enlund F, Behboudi A, Andrén Y, Oberg C, Lendahl U, Mark J, Stenman G. Altered Notch signaling resulting from expression of a WAMTP1-MAML2 gene fusion in mucoepidermoid carcinomas and benign Warthin's tumors. Exp Cell Res. 2004; 292: 21-88.
31. Martins C, Cavaco B, Tonon G, Kaye FJ, Soares J, Fonseca I. A study of MECT1-MAML2 in mucoepidermoid carcinoma and Warthin's tumor of salivary glands. J Mol Diagn. 2004; 6: 205-10.
32. Behboudi A, Enlund F, Winnes M, Andrén Y, Nordkvist A, Leivo I, Flaberg E, Szekely L, Mäkitie A, Grenman R, Mark J, Stenman G. Molecular classification of mucoepidermoid carcinomas-prognostic significance of the MECT1-MAML2 fusion oncogene. Genes Chromosomes Cancer. 2006; 45: 470-81.
33. Tirado Y, Williams MD, Hanna EY, Kaye FJ, Batsakis JG, El-Naggar AK. CRTC1/MAML2 fusion transcript in high grade mucoepidermoid carcinomas of salivary and thyroid glands and Warthin's tumors: implications for histogenesis and biologic behavior. Genes Chromosomes Cancer. 2007; 46: 708-15.
34. Seethala RR, Dacic S, Cieply K, Kelly LM, Nikiforova MN. A reappraisal of the MECT1/MAML2 translocation in salivary mucoepidermoid carcinomas. Am J Surg Pathol. 2010; 34: 1106-21.
35. Fehr A, Meyer A, Heidorn K, Röser K, Löning T, Bullerdiek J. A link between the expression of the stem cell marker HMGA2, grading, and the fusion CRTC1-MAML2 in mucoepidermoid carcinoma. Genes Chromosomes Cancer. 2009; 48: 777-85.
36. Coxon A, Rozenblum E, Park YS, Joshi N, Tsurutani J, Dennis PA, Kirsch IR, Kaye FJ. Mect1-Maml2 fusion oncogene linked to the aberrant activation of cyclic AMP/CREB regulated genes. Cancer Res. 2005; 65: 7137-44.
37. Wu L, Liu J, Gao P, Nakamura M, Cao Y, Shen H, Griffin JD. Transforming activity of MECT1-MAML2 fusion oncoprotein is mediated by constitutive CREB activation. EMBO J. 2005; 24: 2391-402.
38. Nakayama T, Miyabe S, Okabe M, Sakuma H, Ijichi K, Hasegawa Y, Nagatsuka H, Shimozato K, Inagaki H. Clinicopathological significance of the CRTC3-MAML2 fusion transcript in mucoepidermoid carcinoma. Mod Pathol. 2009; 22: 1575-81.
39. Fontaine V, van der Meijden E, ter Schegget J. Inhibition of human papillomavirus-16 long control region activity by interferon-gamma overcome by p300 overexpression. Mol Carcinog. 2001; 31: 27-36.
40. Tidy J, Vousden KH, Mason P, Farrell PJ. A novel deletion within the upstream regulatory region of episomal human papillomavirus type 16. J Gen Virol. 1989; 70: 999-1004.
41. Isayeva T, Li Y, Maswahu D, Brandwein-Gensler M. Human papillomavirus in non-oropharyngeal head and neck cancers: a systematic literature review. Head Neck Pathol. 2012; 6(Suppl 1): 104-20.